Power Law company profile

Medartis

Health Tech & Medtech · Basel, Switzerland · Founded 1997 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$944M

Market cap · Apr/2026

Revenue

$247M

Latest reported FY

Patent intelligence

$32M patent portfolio · 79 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$32M

3.3% of market cap · 15.9× smaller than top peer Insulet ($502M)

79 active patent families

Where Medartis innovates Biomedical engineeringAnatomySurgeryIliac screwGeneral surgery

Below peer median on Strategic

Quality vs same-sector peers

Medartis on the five Patsnap quality dimensions

Medartis in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Medartis concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Medartis and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Medartis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo